Drug-eluting balloons: Effective and durable treatment for in-stent restenosis

JACC: Cardiovascular Interventions

Volumn 6, Issue 6, 2013, Pages 577-579

  Samady, Habib ^a   Mekonnen, Girum ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug eluting balloon(s); in stent restenosis; percutaneous transluminal coronary angioplasty

Indexed keywords

BARE METAL STENT; CARDIAC PATIENT; CLINICAL PRACTICE; DRUG ELUTING STENT; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; NOTE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 84879351425     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.04.002     Document Type: Editorial

References (29)

1. S.B. King 3rd, and M. Schlumpf Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience J Am Coll Cardiol 22 1993 353 360
2. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 316 1987 701 706
3. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
4. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264
5. I. Bossi, C. Klersy, and A.J. Black In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty J Am Coll Cardiol 35 2000 1569 1576
6. S. Strikwerda, E. Montauban van Swijndregt, and D.P. Foley Immediate and late outcome of excimer laser and balloon coronary angioplasty: a quantitative angiographic comparison based on matched lesions J Am Coll Cardiol 26 1995 939 946
7. C. Hehrlein, J.J. DeVries, and A. Arab Failure of a novel balloon-expandable gamma-emitting ((103)Pd) stent to prevent edge effects Circulation 104 2001 2358 2362
8. R. Albiero, M. Adamian, and N. Kobayashi Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: the Milan Dose-Response Study Circulation 101 2000 18 26
9. F. Alfonso, M.J. Perez-Vizcayno, and J. Dutary Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]) J Am Coll Cardiol Intv 5 2012 728 737
10. P.A. Lemos, A. Hoye, and D. Goedhart Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
11. C. Dommke, K.K. Haase, and T. Suselbeck Local paclitaxel delivery after coronary stenting in an experimental animal model Thromb Haemost 98 2007 674 680
12. C. Herdeg, M. Oberhoff, and A. Baumbach Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J Am Coll Cardiol 35 2000 1969 1976
13. D.I. Axel, W. Kunert, and C. Goggelmann Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645
14. B. Scheller, C. Hehrlein, and W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
15. K. Bonaventura, A.W. Leber, and C. Sohns Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease Clin Res Cardiol 101 2012 573 584
16. M. Werk, S. Langner, and B. Reinkensmeier Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
17. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
18. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
19. S. Habara, K. Mitsudo, and K. Kadota Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 149 154
20. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
21. R.A. Byrne, F.J. Neumann, and J. Mehilli Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
22. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
23. A. Indermuehle, R. Bahl, and A.J. Lansky Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials Heart 99 2013 327 333
24. P. Agostoni, A. Belkacemi, M. Voskuil, H.M. Nathoe, P.A. Doevendans, and P.R. Stella Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography and fractional flow reserve J Am Coll Cardiol Intv 6 2013 569 576
25. J. Mehilli, R.A. Byrne, and K. Tiroch Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
26. J.F. LaDisa Jr., L.E. Olson, H.A. Douglas, D.C. Warltier, J.R. Kersten, and P.S. Pagel Alterations in regional vascular geometry produced by theoretical stent implantation influence distributions of wall shear stress: analysis of a curved coronary artery using 3D computational fluid dynamics modeling Biomed Eng Online 5 2006 40
27. H. Samady, P. Eshtehardi, and M.C. McDaniel Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease Circulation 124 2011 779 788
28. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
29. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 e1 e121